![Harry Lamble](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Harry Lamble
Bedrijven | Functie | Begin | Einde |
---|
Loopbaan van Harry Lamble
Eerdere bekende functies van Harry Lamble
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Sense Biodetection Ltd.
![]() Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom. | Directeur/Bestuurslid | 01-01-2014 | 30-01-2023 |
Algemeen Directeur | 01-01-2014 | 20-07-2021 | |
Oprichter | 01-01-2014 | 30-01-2023 | |
Corporate Officer/Principal | 20-07-2021 | 30-01-2023 | |
Oxford BioTherapeutics Ltd.
![]() Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Directeur/Bestuurslid | 17-12-2009 | - |
Bedrijfssecretaris | - | - |
Opleiding van Harry Lamble
University of Bath | Doctorate Degree |
Cranfield University | Masters Business Admin |
Statistieken
Internationaal
Verenigd Koninkrijk | 5 |
Operationeel
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Oxford BioTherapeutics Ltd.
![]() Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Sense Biodetection Ltd.
![]() Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom. | Health Services |
- Beurs
- Insiders
- Harry Lamble
- Ervaring